RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

NCT05425654 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Primary CNS Lymphoma

Interventions

DRUG: Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide

Sponsor

National Research Center for Hematology, Russia